Open Q&A Session with the Main Event Late-Breaking Science Trialist(s): Atorvastatin Treatment and Rebleeding in Cerebral Cavernous Malformations: A Randomized, Placebo-Controlled, Double-Blinded Clinical Trial (LB20) - at the Neuro Talk Theater (AHA HeadQuarter’s Booth, Booth 528) - AHA OnDemand Skip to main content

The accreditors of this session require that you periodically check in to verify that you are still attentive. Please click the button below to indicate that you are.






Evaluation